Clinical uses of GM-CSF, a critical appraisal and update.
The role of granulocyte-macrophage-colony-stimulating factor (GM-CSF) in the supportive care of cancer patients has been evaluated with promising results. More recently, GM-CSF has been added to regimens for the mobilization of hematopoietic progenitor cells. An expanding role for GM-CSF in regulating immune responses has been recognized based upon its activity on the development and maturation of antigen presenting cells and its capability for skewing the immune system toward Th1-type responses. GM-CSF has been shown to preferentially enhance both the numbers and activity of type 1 dendritic cells (DC1), the subsets of dendritic cells responsible for initiating cytotoxic immune responses. The increase in DC1 content and activity following local and systemic GM-CSF administration support a role for GM-CSF as an immune stimulant and vaccine adjuvant in cancer patients. GM-CSF has shown clinical activity as an immune stimulant in tumor cell and dendritic cell vaccines, and may increase antibody-dependent cellular cytotoxicity. The successful use of myeloid acting cytokines to enhance anti-tumor responses will likely require the utilization of GM-CSF in combination with cytotoxic or other targeted therapies.
Arellano
Martha
M
Emory University, Winship Cancer Institute, Atlanta, GA, USA.
Lonial
Sagar
S
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13141-6
9789055
Acta Med Scand Suppl. 1953;276:1-103
13039964
J Clin Oncol. 2003 Nov 1;21(21):4016-26
14581425
Blood. 1997 Oct 15;90(8):3037-49
9376584
Blood. 2001 Apr 15;97(8):2514-21
11290617
Blood. 2001 Apr 1;97(7):1942-6
11264156
Blood. 1994 Sep 15;84(6):1737-46
7521686
Oncol Rep. 2005 Apr;13(4):751-6
15756453
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539-43
8097319
Exp Hematol. 1986 Mar;14(3):192-6
2868909
Eur J Immunol. 2001 Sep;31(9):2547-57
11536152
J Exp Med. 1997 Mar 17;185(6):1101-11
9091583
J Exp Med. 2003 May 5;197(9):1213-9
12732663
J Immunother. 2003 Mar-Apr;26(2):130-8
12616104
Blood. 2000 Apr 15;95(8):2484-90
10753825
J Immunol. 2007 Mar 1;178(5):2763-9
17312119
Curr Hematol Rep. 2004 Nov;3(6):406-12
15496273
Exp Hematol. 1981 Jul;9(6):684-90
6114872
Nature. 1998 Mar 19;392(6673):245-52
9521319
J Clin Oncol. 2006 Jul 1;24(19):3187-205
16682719
Cancer. 1996 Mar 15;77(6):1149-53
8635137
Science. 1994 Apr 29;264(5159):713-6
8171324
Blood. 2001 May 15;97(10):2948-56
11342416
J Clin Oncol. 2001 Jan 1;19(1):145-56
11134207
Ann Oncol. 2001 May;12(5):655-9
11432624
Clin Cancer Res. 2000 Apr;6(4):1267-72
10778950
Annu Rev Immunol. 1994;12:991-1045
8011301
Cancer Immunol Immunother. 2001 Sep;50(7):373-81
11676397
Blood. 1996 Mar 15;87(6):2195-204
8630379
J Immunol. 2004 Apr 15;172(8):4733-43
15067049
Exp Hematol. 2007 Aug;35(8):1163-71
17562355
Blood. 2002 Apr 15;99(8):2869-79
11929777
J Natl Cancer Inst. 2001 Jan 3;93(1):31-8
11136839
Biol Blood Marrow Transplant. 2007 Jan;13(1):116-23
17222760
Eur Urol. 2005 Sep;48(3):527-33
16115526
Blood. 1998 Feb 1;91(3):863-9
9446646
Cancer Res. 1999 Oct 15;59(20):5160-8
10537292
Br J Cancer. 2003 Jan 27;88(2):175-80
12610499
Eur J Immunol. 2004 Mar;34(3):796-805
14991609
Cancer Immunol Immunother. 1990;31(4):231-5
2199042
J Exp Med. 1992 Dec 1;176(6):1693-702
1460426
Br J Cancer. 2003 May 6;88(9):1346-51
12778059
J Natl Cancer Inst. 1998 Dec 16;90(24):1894-900
9862627
Eur J Cancer. 1999 Aug;35 Suppl 3:S23-4
10645217
J Immunother. 2002 Mar-Apr;25(2):97-138
12074049
Curr Top Microbiol Immunol. 2003;276:261-75
12797452
Br J Cancer. 2001 Nov 16;85(10):1467-71
11720430
Immunol Cell Biol. 1998 Oct;76(5):441-7
9797465
J Immunother. 1998 Sep;21(5):389-98
9789201
Biol Blood Marrow Transplant. 2005 Aug;11(8):627-36
16041313
J Leukoc Biol. 1992 Sep;52(3):274-81
1387891
Gene Ther. 2000 Aug;7(15):1312-6
10918502
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5592-6
8202532
Blood. 1994 Nov 1;84(9):3054-62
7949177
Cancer Chemother Pharmacol. 2000;46 Suppl:S67-72
10950151
J Clin Oncol. 1996 Jul;14(7):2150-9
8683249
Science. 1999 Jun 11;284(5421):1835-7
10364556
J Immunother. 2001 May-Jun;24(3):257-62
11394504
Leukemia. 2002 Nov;16(11):2197-204
12399962
Cancer Res. 1997 Apr 15;57(8):1537-46
9108457
Bone Marrow Transplant. 2002 Feb;29(4):303-12
11896427
Biol Blood Marrow Transplant. 2004 Dec;10(12):848-57
15570253
Cancer Immunol Immunother. 2004 Feb;53(2):125-34
14600790
Stem Cells Dev. 2006 Apr;15(2):269-77
16646673
J Exp Med. 2002 Mar 18;195(6):695-704
11901196
Blood. 1995 Jul 15;86(2):457-62
7605984
Best Pract Res Clin Haematol. 2004 Sep;17(3):439-51
15498715
J Immunol Methods. 2000 May 26;239(1-2):95-107
10821951
Eur J Cancer. 1999 Aug;35 Suppl 3:S33-5
10645220
Oncol Rep. 2003 Jan-Feb;10(1):127-31
12469157
Drugs. 2006;66(6):791-820
16706552
Eur J Cancer. 2003 Nov;39(16):2264-72
14556916
Bone Marrow Transplant. 1998 May;21(10):995-1003
9632272
Clin Cancer Res. 1997 Dec;3(12 Pt 2):2623-9
10068264
J Exp Med. 2001 Sep 17;194(6):863-9
11561001
Cancer. 2000 Apr 15;88(8):1892-901
10760767
J Exp Med. 1998 Dec 21;188(12):2357-68
9858522
Cytokine. 2002 Apr 7;18(1):8-19
12090755
Clin Cancer Res. 1999 Jun;5(6):1289-97
10389911
Lancet. 2001 Feb 17;357(9255):539-45
11229684
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12551-6
9356487
Cancer Biother Radiopharm. 1998 Jun;13(3):155-64
10850351
Leukemia. 1998 Jun;12(6):860-4
9639411
Leuk Res. 2005 Jul;29(7):735-8
15927668
Biol Blood Marrow Transplant. 2004 Aug;10(8):540-51
15282532
Blood. 2003 May 1;101(9):3520-6
12511409
J Clin Oncol. 2005 Dec 10;23(35):8992-9000
16260693
Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):540-9
17255276
Blood. 2004 Jun 1;103(11):4330-5
14962904
Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001425
15674877
Nat Med. 1999 Oct;5(10):1171-7
10502821
Cancer Immunol Immunother. 2002 Dec;51(11-12):630-6
12439608
J Clin Invest. 1999 Feb;103(4):563-9
10021465
Blood. 2004 Jul 1;104(1):281-9
15010368
J Clin Oncol. 2003 Sep 1;21(17):3343-50
12947071
Br J Haematol. 2003 Feb;120(3):442-51
12580958
In Vivo. 2003 Jan-Feb;17(1):73-5
12655794
N Engl J Med. 2001 Jan 18;344(3):175-81
11172139
Annu Rev Immunol. 2000;18:767-811
10837075
Blood. 2001 Nov 15;98(10):2900-8
11698269
Curr Opin Immunol. 2007 Apr;19(2):217-23
17306521
Leukemia. 2000 Mar;14(3):412-8
10720135
Cytokine Growth Factor Rev. 2002 Apr;13(2):185-93
11900993
Cancer Res. 2003 Dec 15;63(24):9007-15
14695219
Cancer Immunol Immunother. 2001 Feb;49(12):641-8
11258790
J Clin Oncol. 2006 Dec 10;24(35):5601-8
17158546
Ann Oncol. 2000 Sep;11(9):1183-9
11061616
Curr Opin Oncol. 2007 Mar;19(2):121-7
17272984
J Immunother. 1999 Mar;22(2):166-74
10093041
J Clin Oncol. 2003 Feb 15;21(4):624-30
12586798
Med Hypotheses. 2002 Feb;58(2):115-9
11812185
Leuk Res. 2001 Jan;25(1):99-100
11203684
Science. 1999 Feb 19;283(5405):1183-6
10024247
Urol Oncol. 2006 Sep-Oct;24(5):419-24
16962494
Leuk Res. 2000 May;24(5):411-5
10785263
Exp Hematol. 2003 Oct;31(10):959-65
14550812
Cancer. 2000 Mar 15;88(6):1317-24
10717612
J Immunother. 2000 Jan;23(1):48-58
10687137
J Clin Oncol. 2004 Feb 1;22(3):416-23
14691124
Cancer Immunol Immunother. 2001 Jan;49(11):613-20
11225992
Nat Med. 1996 Jan;2(1):52-8
8564842
Blood. 1997 Nov 1;90(9):3245-87
9345009
Blood. 2002 Aug 1;100(3):761-7
12130483
Am J Physiol Lung Cell Mol Physiol. 2001 Nov;281(5):L1210-8
11597913
Cell. 2004 May 14;117(4):515-26
15137944
Gene. 1997 Apr 29;190(1):211-6
9185869